Gingipain Inhibitors: The Alzheimer's Drug That Failed and Was Reborn
The rise, fall, and resurrection of a drug designed to block gum disease bacteria in the brain tells you everything about where Alzheimer’s research is heading.
Clinical Trials
The rise, fall, and resurrection of a drug designed to block gum disease bacteria in the brain tells you everything about where Alzheimer’s research is heading.
Get new posts in your inbox
No spam. No sales pitches. Just the science.
By subscribing, you agree to receive email updates. Unsubscribe anytime. Privacy
Like what you're reading?
Get new posts delivered. No spam, just the science.
By subscribing, you agree to receive email updates. Unsubscribe anytime.